股价大涨！600亿龙头收购，实控人刚宣布减持

Core Viewpoint - Tiger Med voluntarily disclosed the acquisition of 56.37% stake in Japanese company MICRON, despite the transaction amount not meeting mandatory disclosure standards [2][5]. Group 1: Acquisition Details - Tiger Med's wholly-owned subsidiary, Tiger Med Japan, signed a share transfer agreement to purchase part of MICRON's shares for a total price of 484 million JPY, approximately 23.48 million CNY [5]. - Following the completion of this transfer, Tiger Med will hold 56.37% of MICRON [5]. - MICRON, established in 2005 and headquartered in Tokyo, specializes in medical imaging and clinical trial services, employing over 160 people and serving more than 250 clients [5]. Group 2: Financial Overview - As of May 31, 2025, MICRON's total assets were 781 million JPY, with a net asset value of -452 million JPY [6]. - For the period from January to May 2025, MICRON reported a main business revenue of 940 million JPY and a net loss of 67.05 million JPY [6]. Group 3: Strategic Implications - The acquisition is expected to leverage MICRON's strong foundation and customer resources in the Japanese market, facilitating Tiger Med's expansion in Japan and the Asia-Pacific region [6]. - The collaboration aims to enhance the integration of technology and talent, strengthening the competitive edge in medical imaging and clinical services, which is anticipated to positively impact the company's future operations [6]. Group 4: Market Reaction - Following the announcement, Tiger Med's stock price surged, with A-shares increasing by 8.8% and H-shares rising by 9.45% [6]. - As of July 29, the market capitalization of Tiger Med's A-shares reached 59.18 billion CNY [6]. Group 5: Recent Developments - Coincidentally, on July 28, Tiger Med announced that its actual controller, Cao Xiaochun, plans to reduce his holdings by up to 3 million shares within three months, potentially cashing out around 200 million CNY at current stock prices [9].